Katia Alves

1.3k citations

21 papers · 720 indexed · h-index 12

Hepatology top 2%
- Hepatitis C virus research 11
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 9
- HIV/AIDS Research and Interventions 4
Virology top 5%
- HIV Research and Treatment 3
Epidemiology top 10%
- Hepatitis B Virus Studies 5
- Liver Disease Diagnosis and Treatment 4
- Fungal Infections and Studies 3
Transplantation top 10%
Pharmacology
- Drug-Induced Hepatotoxicity and Protection 3

Co-authors: Varun Garg Rolf van Heeswijk Jee Eun Lee Xia Luo Priya Nadkarni Gurudatt Chandorkar Kian Karimi Patricia Connolly
Cited by: Hepatology Infectious Diseases Virology
Partner nations: United States Brazil Japan

In The Last Decade

Katia Alves

21 papers receiving 702 citations

Peers

Countries citing papers authored by Katia Alves

Since Specialization

Citations

This map shows the geographic impact of Katia Alves's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katia Alves with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katia Alves more than expected).

Fields of papers citing papers by Katia Alves

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katia Alves. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katia Alves. The network helps show where Katia Alves may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Katia Alves, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Katia Alves Line = papers co-authored together Katia Alves links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	LBP-12-Phase 1a Study of the Safety, Tolerability and Pharmacokinetics of ABI-H, a Novel Second-Generation HBV Core Inhibitor, in Healthy Volunteers Edward Gane,Christian Schwabe,Marc Evanhcik,Eric Ruby,Sandy Liaw,Katia Alves,Richard J. Colonno,Uri Lopatin	2019	2
2	Pharmacokinetics of Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir in Healthy Chinese Subjects and HCV GT1b-Infected Chinese, South Korean and Taiwanese Patients Jiuhong Zha,Bifeng Ding,Haoyu Wang,Weihan Zhao,Chen Yu,Katia Alves,Niloufar Mobashery,Yan Luo,Rajeev Menon	2018	1
3	Randomized Phase 3 Trial of Ombitasvir/Paritaprevir/Ritonavir and Ribavirin for Hepatitis C Virus Genotype 2-Infected Japanese Patients Ken Sato,Kazuaki Chayama,Katia Alves,Hidenori Toyoda,Fumitaka Suzuki,Koji Kato,Lino Rodrigues,Xinyan Zhang,Carolyn M. Setze,Edward Tam,Margaret Burroughs,Rebecca Redman,Hiromitsu Kumada	2017	9
4	Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection Hiromitsu Kumada,Tsunamasa Watanabe,Fumitaka Suzuki,Kenji Ikeda,Ken Sato,Hidenori Toyoda,Masanori Atsukawa,Akio Ido,Akinobu Takaki,Nobuyuki Enomoto,Koji Kato,Katia Alves,Margaret Burroughs,Rebecca Redman,David Pugatch,Edward Tam,Preethi Krishnan,Rajneet K. Oberoi,Wangang Xie,Kazuaki Chayama	2017	75
5	Resistance characterization of hepatitis C virus genotype 2 from Japanese patients treated with ombitasvir and paritaprevir/ritonavir Gretja Schnell,Rakesh Tripathi,Preethi Krishnan,Jill Beyer,Thomas Reisch,Michelle Irvin,Tatyana Dekhtyar,Carolyn M. Setze,Lino Rodrigues,Katia Alves,Margaret Burroughs,Rebecca Redman,Kazuaki Chayama,Hiromitsu Kumada,Christine A. Collins,Edward Tam	2017	11
6	Drug Interactions Between Hepatoprotective Agents Ursodeoxycholic Acid or Glycyrrhizin and Ombitasvir/Paritaprevir/Ritonavir in Healthy Japanese Subjects Jiuhong Zha,Prajakta Badri,Bifeng Ding,Naotaka Uchiyama,Katia Alves,Lino Rodrigues,Rebecca Redman,Sandeep Dutta,Rajeev Menon	2015	11
7	VX-222, a non-nucleoside NS5B polymerase inhibitor, in telaprevir-based regimens for genotype 1 hepatitis C virus infection Adrian M. Di Bisceglie,Mark Sulkowski,Ed Gane,Ira M. Jacobson,David R. Nelson,Cynthia DeSouza,Katia Alves,Shelley George,Tara L. Kieffer,Eileen Z. Zhang,Robert S. Kauffman,Mohammed Asmal,Margaret James Koziel	2014	12
8	Long-term follow-up of patients receiving boceprevir for treatment of chronic hepatitis C A Howe,Jianmin Long,David C. Nickle,Richard Barnard,Seth Thompson,John A. Howe,Katia Alves,Janice Wahl	2014	19
9	<b>Structural features and assessment of zymosan-induced arthritis in rat temporomandibular joint model using sulfated polysaccharide José Ariévilo Gurgel Rodrigues,Hellíada Vasconcelos Chaves,Katia Alves,Adriano Aguiar Filgueira,Mirna Marques Bezerra,Norma Maria Barros Benevídes	2014	8
10	The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers Varun Garg,Gurudatt Chandorkar,Yijun Yang,Nathalie Adda,Lindsay McNair,Katia Alves,Frances Smith,Rolf P. G. van Heeswijk	2012	35
11	Effect of Telaprevir on the Pharmacokinetics of Midazolam and Digoxin Varun Garg,Gurudatt Chandorkar,Hayley Farmer,Frances Smith,Katia Alves,Rolf P. G. van Heeswijk	2011	49
12	Effect of the Hepatitis C Virus Protease Inhibitor Telaprevir on the Pharmacokinetics of Amlodipine and Atorvastatin Jee Eun Lee,Rolf van Heeswijk,Katia Alves,Frances Smith,Varun Garg	2011	57
13	Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus Varun Garg,Rolf van Heeswijk,Jee Eun Lee,Katia Alves,Priya Nadkarni,Xia Luo	2011	195
14	Análise espacial das internações por pneumonia na região do Vale do Paraíba (SP) Adriana Mukai,Luiz Fernando Costa Nascimento,Katia Alves	2009	11
15	High Levels of Primary Antiretroviral Resistance Genotypic Mutations And B/F Recombinants in Santos, Brazil Maria Cecília Araripe Sucupira,Marcos Montani Caseiro,Katia Alves,Graziela Tescarollo,Luiz Mário Janini,Éster Cerdeira Sabino,Adauto Castelo,Kimberly Page,Ricardo Sobhie Diaz	2007	41
16	Pathogenic Differences between North American and Latin American Strains of Histoplasma capsulatum var. capsulatum in Experimentally Infected Mice Michelle Durkin,Patricia Connolly,Kian Karimi,Emerson Wheat,Carol Schnizlein‐Bick,Stephen D. Allen,Katia Alves,Ram P. Tewari,Elizabeth J. Keath	2004	31
17	HIV Type 1 Envelope Quasispecies in the Thymus and Lymph Nodes of AIDS Patients Katia Alves,Mauro Canzian,Eric Delwart	2002	11
18	Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors Daisy Maria Machado,Eric Delwart,Ricardo Sobhie Diaz,Carlos Fernando de Oliveira,Katia Alves,B. D. Rawal,Mark Sullivan,Marta Gwinn,Kenneth A. Clark,Michael P. Busch	2002	26
19	Differences in Histoplasmosis in Patients with Acquired Immunodeficiency Syndrome in the United States and Brazil Kian Karimi,L. Joseph Wheat,Patricia Connolly,Gretchen Cloud,Rana Hajjeh,Emerson Wheat,Katia Alves,Carlos da Silva Lacaz,Elizabeth J. Keath	2002	84
20	Histoplasmose disseminada e síndrome de imunodeficiência adquirida. Estudo clínico-laboratorial de 28 casos Katia Alves	1998	4

About Katia Alves

Katia Alves is a scholar working on Hepatology, Infectious Diseases and Virology, having authored 21 papers that have together received 720 indexed citations. Recurring topics across this work include Hepatitis C virus research (11 papers), HIV/AIDS drug development and treatment (9 papers), Hepatitis B Virus Studies (5 papers), HIV/AIDS Research and Interventions (4 papers), Liver Disease Diagnosis and Treatment (4 papers), HIV Research and Treatment (3 papers), Fungal Infections and Studies (3 papers) and Drug-Induced Hepatotoxicity and Protection (3 papers). The work is most often cited by research in Hepatology (399 citations), Infectious Diseases (353 citations) and Virology (84 citations). Katia Alves has collaborated with scholars based in United States, Brazil and Japan. Frequent co-authors include Varun Garg, Rolf van Heeswijk, Jee Eun Lee, Xia Luo, Priya Nadkarni, Gurudatt Chandorkar, Kian Karimi, Patricia Connolly, Rolf P. G. van Heeswijk and Elizabeth J. Keath.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact